[1] 肖倩倩, 王子璇, 范建高. 肝豆状核变性临床表型的影响因素. 中华肝脏病杂志, 2023, 31(2):207-211. [2] 卢致琨, 程静, 黎丝敏, 等. 肝豆状核变性患儿316例临床表型和ATP7B基因变异特征. 中华儿科杂志, 2022, 60(4): 317-322. [3] Purcaru MAP, Repanovici A. Non-invasive assessment method using thoracic-abdominal profile image acquisition and mathematical modeling with Bezier curves. J Clin Med, 2019, 8(1): 65. [4] Surasi DSS, Jazbeh S, Nicek ZS, et al. Utility of longitudinal measurement of the liver with ultrasound in comparison to computed tomography liver volume in assessing hepatomegaly. Ultrasound Q, 2019, 37(2): 198-203. [5] Rafati I, Destrempes F, Yazdani L, et al. Regularized ultrasound phantom-free localattenuation coefficient slope (ASC) imaging in homogeneous and heterogeneous tissues. IEEE Trans Ultrason Ferroelectr Freq Control, 2022, 69(12): 3338-3352. [6] 中华医学会神经病学分会神经遗传学组. 中国肝豆状核变性诊治指南(2021年). 中华神经科杂志, 2021, 54(4): 310-319. [7] Gao Y, Fan S, Li H, Jet al. Constitutive androstane receptor induced-hepatomegaly and liver regeneration is partially via yes-associated protein activation. Acta Pharm Sin B, 2021, 11(3): 727-737. [8] van Rensburg RJ, Hale S, Calara A, et al. Rapid hepatomegaly from ruxolitinib discontinuation syndrome. HCA Healthc J Med, 2023, 4(2): 199-204. [9] Mamone G, Carollo V, Di Piazza A, et al. Budd-Chiari sand hepatic regenerative nodules: magnetic resonance findings with emphasis of hepatobiliary phase. Eur J Radiol, 2019, 117(1): 15-25. [10] Ferraioli G, Soares Monteiro LB. Ultrasound-based techniques for the diagnosis of liver steatosis. World J Gastroenterol, 2019, 25(40): 6053-6062. [11] Gong P, Zhou C, Song P, et al. Ultrasoundattenuation estimation in harmonic imaging for robust fATIy liver detection. Ultrasound Med Biol, 2020, 46(11): 3080-3087. [12] Diamond BH, Banson K, Ayash J, et al. Outcomes after stereotactic body radiation for hepatocellular carcinoma in patients with Child-Pugh A versus Child-Pugh B/C cirrhosis. Adv Radiat Oncol, 2024, 9(12):101631. [13] Katano A, Nozawa Y, Minamitani M, et al. Stereotactic body radiation therapy for hepatocellular carcinoma in Child-Pugh class C as bridge therapy before liver transplantation. Cureus, 2024, 16(10):e71654. [14] da Fonsecaa LG, de Melob MAZ, da Silveirac THM, et al. Prognostic role of albumin-bilirubin (ALBI) score and Child-Pugh classification in patients with advanced hepatocellular carcinoma under systemic treatment. E Cancer Med Sci, 2024, 18:1748. [15] Brochado-Kith O, Rava M, Berenguer J, et al. Altered blood microbiome in patients with HCV-related Child-Pugh class B cirrhosis. J Infect Public Health, 2024, 17(10):102524. [16] Lawitz EJ, Ertle J, Schoelch C, et al. Hepatic improvement within 27 days of avenciguat treatment in Child-Pugh A cirrhosis detected by an oral cholate challenge test. Liver Transpl, 2024, 30(10):982-990. [17] Miller DL, Lu X, Fabiilli M, et al. Hepatocyte injury induced by contrast-enhanced diagnostic ultrasound. J Ultrasound Med, 2019, 38(7): 1855-1864. [18] Coila A, Oelze ML. Effects of acoustic nonlinearity on pulse-echoattenuation coefficient estimation from tissue-mimicking phantoms. J Acoust Soc Am, 2020, 148(2): 805. [19] Gao J. Ultrasoundattenuation coefficient of the liver and spleen in adults: a preliminary observation. Clin Imaging, 2022, 84(1): 140-148. [20] Radzina M, Putrins DS, Micena A, et al. Post-covid-19 liver injury: comprehensive imaging with multiparametric ultrasound. J Ultrasound Med, 2022, 41(4): 935-949. |